Outcomes and endpoints in cancer trials: bridging the divide-Reference-Cited by-同舟云学术

Outcomes and endpoints in cancer trials: bridging the divide

Published:2015-01 Issue:1 Volume:16 Page:e43-e52
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Wilson Michelle K,Collyar Deborah,Chingos Diana T,Friedlander Michael,Ho Tony W,Karakasis Katherine,Kaye Stan,Parmar Mahesh K B,Sydes Matthew R,Tannock Ian F,Oza Amit M

Publisher

Elsevier BV

Subject

Oncology

Reference98 articles.

1. Reflections on medical oncology: 25 years of clinical trials—where have we come and where are we going?;Booth;J Clin Oncol,2008

2. Outcomes and endpoints in trials of cancer therapy: the past, present, and future;Wilson;Lancet Oncol,2014

3. Oncology drug development and approval of systemic anticancer therapy by the US Food and Drug Administration;Martell;Oncologist,2013

4. The role of the US Food and Drug Administration review process: clinical trial endpoints in oncology;McKee;Oncologist,2010

5. Ultimate fate of oncology drugs approved by the us food and drug administration without a randomized trial;Tsimberidou;J Clin Oncol,2009

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update;Journal of Clinical Oncology;2024-09-11

2. Accelerated Approval for Cancer Drugs in the United States and the Clinical Evidence Required for Conversion to Regular Approval;Journal of Pharmaceutical Innovation;2024-09-04

3. Psychological impacts of lobectomy and total thyroidectomy in PTC measuring 1 to 4 cm with low to intermediate risk of recurrence;Endocrine;2024-06-01

4. Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up;Journal of Clinical Oncology;2024-06-01

5. Status of mental and social activities of young and middle-aged patients after papillary thyroid cancer surgery;Frontiers in Oncology;2024-03-26